Skip to contentI
InfuSystem Holdings, Inc
I
INFUInfuSystem Holdings, Inc Q1 2022 · 10-Q
Revenue$26.76M$26.76M+9.4% vs Q1 2021 Net Income-$368.00K-$368.00KN/M vs Q1 2021 EPS Diluted-$0.02-$0.02N/M vs Q1 2021 Gross Profit$15,367,000+5.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InfuSystem Holdings, Inc · CIK 1337013 · Engraved from SEC EDGAR
Operating Cash Flow$4,078,000+53.8% Free Cash Flowderived$3,900,000+55.2% Margins · derivedGross margin57.4%−2.2 pt vs Q1 2021
Operating margin-2.0%−5.5 pt vs Q1 2021
Net margin-1.4%−4.1 pt vs Q1 2021
ended Mar 31, 2022 · filed May 5, 2022 · 35 d after period end